158 related articles for article (PubMed ID: 31015522)
1. A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy.
Huerta-Nuñez LFE; Gutierrez-Iglesias G; Martinez-Cuazitl A; Mata-Miranda MM; Alvarez-Jiménez VD; Sánchez-Monroy V; Golberg A; González-Díaz CA
Sci Rep; 2019 Apr; 9(1):6419. PubMed ID: 31015522
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity analysis of electrical bioimpedance patterns of breast cancer cells labeled with magnetic nanoparticles: forming the foundation for a biosensor of circulating tumor cells.
González-Díaz CA; Golberg A
Physiol Meas; 2020 Jul; 41(6):064001. PubMed ID: 32413882
[TBL] [Abstract][Full Text] [Related]
3. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.
Strati A; Kasimir-Bauer S; Markou A; Parisi C; Lianidou ES
Breast Cancer Res; 2013 Mar; 15(2):R20. PubMed ID: 23497487
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
7. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.
Chen Q; Yao L; Burner D; Minev B; Lu L; Wang M; Ma W
Clin Transl Oncol; 2019 Apr; 21(4):433-442. PubMed ID: 30218306
[TBL] [Abstract][Full Text] [Related]
8. Dual-target recognition sandwich assay based on core-shell magnetic mesoporous silica nanoparticles for sensitive detection of breast cancer cells.
Wang W; Liu S; Li C; Wang Y; Yan C
Talanta; 2018 May; 182():306-313. PubMed ID: 29501157
[TBL] [Abstract][Full Text] [Related]
9. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
12. Impedance spectroscopy assisted by magnetic nanoparticles as a potential biosensor principle for breast cancer cells in suspension.
Silva JG; Cárdenas RA; Quiróz AR; Sánchez V; Lozano LM; Pérez NM; López J; Villanueva C; González CA
Physiol Meas; 2014 Jun; 35(6):931-41. PubMed ID: 24846525
[TBL] [Abstract][Full Text] [Related]
13. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
[TBL] [Abstract][Full Text] [Related]
14. Gelatin Nanoparticle-Coated Silicon Beads for Density-Selective Capture and Release of Heterogeneous Circulating Tumor Cells with High Purity.
Huang Q; Wang FB; Yuan CH; He Z; Rao L; Cai B; Chen B; Jiang S; Li Z; Chen J; Liu W; Guo F; Ao Z; Chen S; Zhao XZ
Theranostics; 2018; 8(6):1624-1635. PubMed ID: 29556345
[No Abstract] [Full Text] [Related]
15. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
Tewes M; Aktas B; Welt A; Mueller S; Hauch S; Kimmig R; Kasimir-Bauer S
Breast Cancer Res Treat; 2009 Jun; 115(3):581-90. PubMed ID: 18679793
[TBL] [Abstract][Full Text] [Related]
17. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
[TBL] [Abstract][Full Text] [Related]
18. Fiber-Optic Array Scanning Technology (FAST) for Detection and Molecular Characterization of Circulating Tumor Cells.
Ao Z; Liu X
Methods Mol Biol; 2017; 1634():235-246. PubMed ID: 28819856
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles.
Silva JG; Sánchez V; Polo SM; González CA
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4498-501. PubMed ID: 24110733
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
